{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:18:01Z","timestamp":1787865481909,"version":"build-2784847793"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pcad.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:07:21Z","timestamp":1787238441000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obesity, lipids, inflammation, and healthy aging"],"prefix":"10.1016","author":[{"given":"Rishi","family":"Rikhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2026.08.006_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2020.05.018","article-title":"The World Health Organization (WHO) approach to healthy ageing","volume":"139","author":"Rudnicka","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.pcad.2026.08.006_bb0010","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/eurheartj\/ehaf231","article-title":"Healthy ageing in older adults with cardiovascular disease","volume":"46","author":"Schmanske","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0015","series-title":"Handbook of Aging, Health and Public Policy: Perspectives from Asia","first-page":"99","article-title":"Global population aging, 1950\u20132050","author":"Navaneetham","year":"2025"},{"key":"10.1016\/j.pcad.2026.08.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010568","article-title":"Association between life\u2019s essential 8 cardiovascular health metrics with cardiovascular events in the cardiovascular disease lifetime risk pooling project","volume":"17","author":"Ning","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.pcad.2026.08.006_bb0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.122.062457","article-title":"Cardiovascular health and life expectancy among adults in the United States","volume":"147","author":"Ma","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.08.006_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2019.11.062","article-title":"Biological versus chronological aging: JACC focus seminar","volume":"75","author":"Hamczyk","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100560","article-title":"Life\u2019s essential 8: optimizing health in older adults","volume":"2","author":"Kumar","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.pcad.2026.08.006_bb0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.08.006_bb0045","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","article-title":"Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-prevalence of risk factors and disease: a presidential advisory from the American Heart Association","volume":"150","author":"Joynt Maddox","year":"2024","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.pcad.2026.08.006_bb0050","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102325","article-title":"National trends in lipid levels in the United States from 2000 to 2023 using the Epic Cosmos database","volume":"4","author":"Williams","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.pcad.2026.08.006_bb0060","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2026.08.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107238","article-title":"Targeting residual inflammatory risk: the next frontier for atherosclerosis treatment and prevention","volume":"153","author":"Ridker","year":"2023","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jacc.2025.05.024","article-title":"2025 Concise clinical guidance: an ACC expert consensus statement on medical weight management for optimization of cardiovascular health: a report of the American College of Cardiology solution set oversight committee","volume":"86","author":"Gilbert","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0075","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.2337\/dc26-S008","article-title":"Obesity and weight management for the prevention and treatment of diabetes: standards of care in diabetes-2026","volume":"49","author":"American Diabetes Association Professional Practice Committee for D. 8","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2026.08.006_bb0080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.pcad.2026.08.006_bb0085","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/eurheartj\/ehaf216","article-title":"Obesity accelerates cardiovascular ageing","volume":"46","author":"Ruperez","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-138-1-200301070-00008","article-title":"Obesity in adulthood and its consequences for life expectancy: a life-table analysis","volume":"138","author":"Peeters","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0095","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1532-5415.2008.01813.x","article-title":"Obesity, physical function, and mortality in older adults","volume":"56","author":"Lang","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pcad.2026.08.006_bb0100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.125.075327","article-title":"Prospective associations of obesity and obesity severity with 9 cardiovascular outcomes: the cross-cohort collaboration","volume":"153","author":"Dardari","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.08.006_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s13679-024-00571-2","article-title":"Sarcopenic obesity and cardiovascular disease: an overlooked but high-risk syndrome","volume":"13","author":"Mirzai","year":"2024","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.pcad.2026.08.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169548","article-title":"Health outcomes of sarcopenia: a systematic review and meta-analysis","volume":"12","author":"Beaudart","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.pcad.2026.08.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009322","article-title":"Current approach to the diagnosis of sarcopenia in heart failure: a narrative review on the role of clinical and imaging assessments","volume":"15","author":"Mirzai","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2026.08.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13534","article-title":"Deciphering the \u201cobesity paradox\u201d in the elderly: a systematic review and meta-analysis of sarcopenic obesity","volume":"24","author":"Liu","year":"2023","journal-title":"Obes Rev"},{"key":"10.1016\/j.pcad.2026.08.006_bb0125","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.clnu.2024.02.002","article-title":"Associations between sarcopenic obesity and risk of cardiovascular disease: a population-based cohort study among middle-aged and older adults using the CHARLS","volume":"43","author":"Jiang","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.pcad.2026.08.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3604","article-title":"Sarcopenia and sarcopenic obesity and mortality among older people","volume":"7","author":"Benz","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pcad.2026.08.006_bb0135","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and cardiovascular diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.08.006_bb0140","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024","volume":"18","author":"Bays","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","article-title":"Obesity and dyslipidemia","volume":"92","author":"Vekic","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.pcad.2026.08.006_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13098-025-01644-5","article-title":"Association of obesity and LDL subfractions evaluated by body mass index, waist circumference, and diabetes status: the ELSA-Brasil study","volume":"17","author":"Moraes","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.pcad.2026.08.006_bb0155","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/eurjpc\/zwae049","article-title":"Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis","volume":"31","author":"Rikhi","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0160","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2026.08.006_bb0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41366-026-02056-9","article-title":"Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002\u22122022)","volume":"50","author":"Filippatos","year":"2026","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pcad.2026.08.006_bb0170","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","article-title":"Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk","volume":"71","author":"Mongraw-Chaffin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","article-title":"The major inflammatory mediator interleukin-6 and obesity","volume":"58","author":"Eder","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pcad.2026.08.006_bb0180","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.pcad.2026.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/diacare.22.12.1971","article-title":"Body mass index, diabetes, and C-reactive protein among U.S. adults","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2026.08.006_bb0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/obr.12003","article-title":"Obesity and C-reactive protein in various populations: a systematic review and meta-analysis","volume":"14","author":"Choi","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.pcad.2026.08.006_bb0195","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.jcin.2020.09.024","article-title":"Prognostic impact of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention according to BMI","volume":"13","author":"Beyhoff","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2026.08.006_bb0200","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1503\/cmaj.1040769","article-title":"Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training","volume":"172","author":"Nicklas","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.pcad.2026.08.006_bb0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2024.02.003","article-title":"Update to the 2016 American Heart Association cardiorespiratory fitness statement","volume":"83","author":"Ross","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2026.08.006_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2024.01.020","article-title":"2023 update: the importance of cardiorespiratory fitness in the United States","volume":"83","author":"Kaminsky","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2026.08.006_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcad.2025.03.012","article-title":"Stepping up physical activity and fitness is needed for longevity","volume":"89","author":"Lavie","year":"2025","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2026.08.006_bb0220","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s11886-023-01975-7","article-title":"Obesity, cardiorespiratory fitness, and cardiovascular disease","volume":"25","author":"Haidar","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2026.08.006_bb0225","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/HCR.0000000000000525","article-title":"Muscular strength and cardiovascular disease: an updated state-of-the-art narrative review","volume":"40","author":"Carbone","year":"2020","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.pcad.2026.08.006_bb0230","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1249\/MSS.0000000000001822","article-title":"Associations of resistance exercise with cardiovascular disease morbidity and mortality","volume":"51","author":"Liu","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2026.08.006_bb0235","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1097\/HCR.0000000000000696","article-title":"Working toward optimal exercise prescription: strength training should not be overlooked","volume":"42","author":"Kaminsky","year":"2022","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.pcad.2026.08.006_bb0240","article-title":"Reduced risk of cardiovascular diseases after bariatric surgery based on the new predicting risk of cardiovascular disease EVENTs equations","volume":"14","author":"Wang","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2026.08.006_bb0245","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0250","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0255","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41574-025-01160-6","article-title":"Balancing weight and muscle loss in GLP1 receptor agonist therapy","volume":"21","author":"Sanchis-Gomar","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41569-024-01111-0","article-title":"Apolipoprotein B-containing lipoproteins in atherogenesis","volume":"22","author":"Boren","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0275","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0280","first-page":"e1154","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"153","author":"Writing Committee M","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2026.08.006_bb0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12170-025-00760-1","article-title":"Lipoprotein(a) as a causal risk factor for cardiovascular disease","volume":"19","author":"Doherty","year":"2025","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.pcad.2026.08.006_bb0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamacardio.2023.5366","article-title":"Familial hypercholesterolemia variant and cardiovascular risk in individuals with elevated cholesterol","volume":"9","author":"Zhang","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0295","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001236","article-title":"Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010","volume":"3","author":"Mundal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2026.08.006_bb0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.31083\/j.rcm2411311","article-title":"Familial hypercholesterolemia: from clinical suspicion to novel treatments","volume":"24","author":"Mirzai","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0305","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0310","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0315","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0320","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112457","article-title":"Endothelial function in healthy centenarians living in the Madonie\u2019s district (Italy)","volume":"192","author":"Buscemi","year":"2024","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11357-024-01467-8","article-title":"Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet","volume":"47","author":"Summer","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.pcad.2026.08.006_bb0335","doi-asserted-by":"crossref","first-page":"M425","DOI":"10.1093\/gerona\/58.5.M425","article-title":"Cardiovascular advantages among the offspring of centenarians","volume":"58","author":"Terry","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pcad.2026.08.006_bb0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1532-5415.2001.49013.x","article-title":"Offspring of centenarians have a favorable lipid profile","volume":"49","author":"Barzilai","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pcad.2026.08.006_bb0345","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.290.15.2030","article-title":"Unique lipoprotein phenotype and genotype associated with exceptional longevity","volume":"290","author":"Barzilai","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2026.08.006_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11357-010-9172-6","article-title":"Lipid metabolism in long-lived families: the Leiden longevity study","volume":"33","author":"Vaarhorst","year":"2011","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.pcad.2026.08.006_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030495","article-title":"Lipoprotein particle profiles mark familial and sporadic human longevity","volume":"3","author":"Heijmans","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0360","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2024.08.070","article-title":"Oxidized phospholipids and calcific aortic valvular disease","volume":"84","author":"Bhatia","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0365","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10654-022-00956-4","article-title":"Circulating lipoprotein (a) and all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis","volume":"38","author":"Amiri","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0370","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2024.02.031","article-title":"Lipoprotein(a) and long-term cardiovascular risk in a multi-ethnic pooled prospective cohort","volume":"83","author":"Wong","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0375","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/eurheartj\/ehy902","article-title":"High lipoprotein(a) and high risk of mortality","volume":"40","author":"Langsted","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0380","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0129","article-title":"Association of long-term exposure to elevated lipoprotein(a) levels with parental life span, chronic disease-free survival, and mortality risk: a mendelian randomization analysis","volume":"3","author":"Arsenault","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pcad.2026.08.006_bb0385","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamacardio.2018.2258","article-title":"Efficacy and safety of further lowering of low-density lipoprotein cholesterol in patients starting with very low levels: a meta-analysis","volume":"3","author":"Sabatine","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154611","article-title":"Newer and emerging LDL-C lowering agents and implications for ASCVD residual risk","volume":"11","author":"Rikhi","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0395","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists C","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2026.08.006_bb0400","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists C","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2026.08.006_bb0405","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa2511002","article-title":"A placebo-controlled trial of the Oral PCSK9 inhibitor enlicitide","volume":"394","author":"Navar","year":"2026","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.pcad.2026.08.006_bb0410","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMoa2601283","article-title":"In vivo base editing of PCSK9 with VERVE-102 for hypercholesterolemia","volume":"395","author":"Vafai","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0415","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jacc.2021.04.102","article-title":"Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol","volume":"78","author":"Schwartz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.pcad.2026.08.006_bb0420","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/eurheartj\/ehag092","article-title":"Lipoprotein(a)-lowering therapies: a promising future","volume":"47","author":"Zhang","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0425","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.pcad.2026.08.006_bb0430","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2026.08.006_bb0435","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","article-title":"Interleukin-6 in aging and chronic disease: a magnificent pathway","volume":"61","author":"Maggio","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pcad.2026.08.006_bb0440","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0197-4580(94)90066-3","article-title":"Interleukin-6 and selected plasma proteins in healthy persons of different ages","volume":"15","author":"Hager","year":"1994","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pcad.2026.08.006_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111804","article-title":"Sex and age differences in the association between high sensitivity C-reactive protein and all-cause mortality: a 12-year prospective cohort study","volume":"211","author":"Bafei","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pcad.2026.08.006_bb0450","doi-asserted-by":"crossref","first-page":"M709","DOI":"10.1093\/gerona\/55.12.M709","article-title":"Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging","volume":"55","author":"Taaffe","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pcad.2026.08.006_bb0455","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/gerona\/59.3.M242","article-title":"Inflammatory markers and physical performance in older persons: the InCHIANTI study","volume":"59","author":"Cesari","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pcad.2026.08.006_bb0460","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1532-5415.1999.tb01583.x","article-title":"Serum IL-6 level and the development of disability in older persons","volume":"47","author":"Ferrucci","year":"1999","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.pcad.2026.08.006_bb0465","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacc.2026.04.015","article-title":"The prognostic value of serum interleukin-6 concentrations for 9 cardiovascular and mortality outcomes: the cross cohort collaboration (CCC)","volume":"88","author":"Yao","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0470","first-page":"1799","article-title":"C-reactive protein and cardiovascular risk in the general population","volume":"47","author":"Kurt","year":"2025","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.pcad.2026.08.006_bb0475","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the American College of Cardiology","volume":"87","author":"Mensah","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0480","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0485","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0490","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0495","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","article-title":"Low-dose colchicine for atherosclerosis: long-term safety","volume":"45","author":"Nidorf","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0500","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0505","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0510","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1093\/eurheartj\/ehaf281","article-title":"Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events","volume":"46","author":"Markus","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2026.05.005","article-title":"Comparative associations of LDL-C, Lp(a), hsCRP, and IL-6 with cardiovascular risk: insights from the United Kingdom (UK) biobank and the multi-ethnic study of atherosclerosis (MESA)","author":"McParland","year":"2026","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2026.08.006_bb0520","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1093\/eurheartj\/ehaf209","article-title":"Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study","volume":"46","author":"Kraaijenhof","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2026.08.006_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2026.05.006","article-title":"Combined LDL-C, Lp(a), and hsCRP assessment predicts ASCVD in the multiethnic HELIUS cohort","author":"Annink","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0530","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2026.08.006_bb0535","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S0029665110001539","article-title":"Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study","volume":"69","author":"Estruch","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.pcad.2026.08.006_bb0540","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41569-023-00984-x","article-title":"Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease","volume":"21","author":"Fredman","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2026.08.006_bb0545","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/ATVBAHA.119.313286","article-title":"Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid","volume":"40","author":"Mason","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:24:24Z","timestamp":1787862264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062026000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":109,"alternative-id":["S0033062026000794"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2026.08.006","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity, lipids, inflammation, and healthy aging","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}